Fertility warning
This medicine may affect fertility.
Leaflet VINBLASTINA TEVA 1mg / ml solution for injection
- Product code:
- W59211001
- Quantity:
- 1
- Indicated for:
- cancer
- Route of administration:
- injectable
- Substance:
- vinblastine (antineoplastic agent)
- ATC
- L01CA01 — Antineoplastic and immunomodulating agents | Plant alkaloids and other natural products | Vinca alkaloids and analogues
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Neuropathy / neurotoxicity
This medicine may affect the nerves or nervous system.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Vinblastine is a chemotherapy medication used for the treatment of various types of cancer, including Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, and breast cancer. It belongs to the vinca alkaloid class and works by inhibiting tubulin polymerization, leading to the arrest of cell division and tumor cell death.
Vinblastine is administered intravenously, usually once a week, and the dosage is adjusted based on body weight and patient response. Treatment is conducted under the supervision of an oncologist, and patients are monitored for signs of toxicity.
Common side effects include nausea, vomiting, hair loss, fatigue, and myelosuppression (reduction in blood cell counts). In rare cases, severe adverse reactions such as peripheral neuropathy or liver function impairment may occur.
Vinblastine is an important component of many chemotherapy regimens, helping to reduce tumor size and improve survival rates in cancer patients.
Vinblastine is administered intravenously, usually once a week, and the dosage is adjusted based on body weight and patient response. Treatment is conducted under the supervision of an oncologist, and patients are monitored for signs of toxicity.
Common side effects include nausea, vomiting, hair loss, fatigue, and myelosuppression (reduction in blood cell counts). In rare cases, severe adverse reactions such as peripheral neuropathy or liver function impairment may occur.
Vinblastine is an important component of many chemotherapy regimens, helping to reduce tumor size and improve survival rates in cancer patients.
General data about VINBLASTINA TEVA 1mg / ml
- Substance:
- vinblastine
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W59211001
- Concentration:
- 1mg / ml
- Pharmaceutical form:
- solution for injection
- Quantity:
- 1
- Product type:
- Generic medicine
- Price:
- 90.81 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for vinblastine
Concentrations available for vinblastine
- 1mg/ml
- 5mg